Responses
Regular and Young Investigator Award Abstracts
Immune Cell Types and Biology
1002 Intratumor heterogeneity in MHC-I expression drives immunotherapy resistance and exposes NKG2A as a therapeutic target in breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
